drugset / Trial / NCT02333318

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

NCT02333318

Phase 1 Completed 24 enrolled Vivozon, Inc.
RandomizedParallel-groupTriple-blindHealth-services research

Summary

The objective of this study is to investigate the safety, tolerability and pharmacokinetics (PK) of VVZ-149 injection after a single dose or loading/maintenance dose in healthy older male volunteers.

Timeline

Start
2014-07
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 0.55 mg/kg Intravenous
Subject VVZ-149 Small molecule 1.1 mg/kg Intravenous
Subject VVZ-149 Small molecule 2.5 mg/kg Intravenous
Subject VVZ-149 Small molecule 5 mg/kg Intravenous

Indications

No indication recorded.